Glutamate utilization fuels rapid production of mitochondrial ROS in dendritic cells and drives systemic inflammation during tularemia.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40880474.
- Also identified by DOI 10.1126/sciadv.adu6271 and PMC identifier 12396335.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Dendritic cells (DCs) hijacked by intracellular bacteria contribute to pathogen dissemination and immunopathology. How bacteria achieve DC subversion remains largely unknown. Here, we describe the mechanism used by tularemia agent <i>Francisella tularensis</i> exploiting host mitochondrial anaplerosis. Shortly after internalization, <i>Francisella</i> associates with DC mitochondria, which leads to the rapid repurposing of their oxidative metabolism for production of mitochondrial reactive oxygen species (mtROS). Mitochondrial metabolic rewiring is orchestrated by the intramitochondrial signaling mediated by protein acetylation and involves switching to glutamate as the primary substrate for DC tricarboxylic acid cycle. Rather than killing the bacterium, glutamate-fueled mtROS production activates p38-dependent proinflammatory gene expression. Blocking of glutamate utilization prevents DC activation and bacterial dissemination and alleviates inflammation in vivo. Our findings underscore the importance of metabolic plasticity in antibacterial DC response and open up potential avenues for therapies targeting host metabolism.
Medical subject headings
- Dendritic Cells
- Tularemia
- Mitochondria
- Reactive Oxygen Species
- Francisella tularensis
- Glutamic Acid
- Inflammation